CB1 Cannabinoid Receptors and their Associated Proteins, Current Medicinal Chemistry, vol.17, issue.14, pp.1382-1393, 2010. ,
DOI : 10.2174/092986710790980023
The pharmacology of cannabinoid receptors and their ligands: an overview, International Journal of Obesity, vol.353, pp.13-18, 2006. ,
DOI : 10.1124/mol.105.016162
Biology of endocannabinoid synthesis system, Prostaglandins & Other Lipid Mediators, vol.89, issue.3-4, pp.112-119, 2009. ,
DOI : 10.1016/j.prostaglandins.2008.12.002
Leptin-regulated endocannabinoids are involved in maintaining food intake, Nature, vol.410, issue.6830, pp.822-825, 2001. ,
DOI : 10.1038/35071088
The Endocannabinoid System in Energy Homeostasis and the Etiopathology of Metabolic Disorders, Cell Metabolism, vol.17, issue.4, pp.475-490, 2013. ,
DOI : 10.1016/j.cmet.2013.03.001
CB1 antagonists for obesity???what lessons have we learned from rimonabant?, Nature Reviews Endocrinology, vol.14, issue.11, pp.633-638, 2009. ,
DOI : 10.1038/nrendo.2009.197
CB1 Antagonism Exerts Specific Molecular Effects on Visceral and Subcutaneous Fat and Reverses Liver Steatosis in Diet-Induced Obese Mice, Diabetes, vol.59, issue.4, pp.926-934, 2010. ,
DOI : 10.2337/db09-1482
URL : https://hal.archives-ouvertes.fr/inserm-01344504
Peripheral, but Not Central, CB1 Antagonism Provides Food Intake-Independent Metabolic Benefits in Diet-Induced Obese Rats, Diabetes, vol.57, issue.11, pp.2977-2991, 2008. ,
DOI : 10.2337/db08-0161
Cannabinoid Receptor Type 1 (CB1R) Signaling Regulates Hepatic Gluconeogenesis via Induction of Endoplasmic Reticulum-bound Transcription Factor cAMP-responsive Element-binding Protein H (CREBH) in Primary Hepatocytes, Journal of Biological Chemistry, vol.286, issue.32, pp.27971-27979, 2011. ,
DOI : 10.1074/jbc.M111.224352
Hepatic Cannabinoid Receptor-1 Mediates Diet-Induced Insulin Resistance via Inhibition of Insulin Signaling and Clearance in Mice, Gastroenterology, vol.142, issue.5, pp.1218-1219, 2012. ,
DOI : 10.1053/j.gastro.2012.01.032
Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice, Journal of Clinical Investigation, vol.118, issue.9, pp.3160-3169, 2008. ,
DOI : 10.1172/JCI34827
Differential distribution of functional cannabinoid CB1 receptors in the mouse gastroenteric tract, European Journal of Pharmacology, vol.459, issue.1, pp.97-105, 2003. ,
DOI : 10.1016/S0014-2999(02)02830-3
Localisation of cannabinoid CB1 receptor immunoreactivity in the guinea pig and rat myenteric plexus, The Journal of Comparative Neurology, vol.20, issue.4, pp.410-422, 2002. ,
DOI : 10.1002/cne.10270
receptors in human ileum, British Journal of Pharmacology, vol.58, issue.7, pp.1393-1395, 1998. ,
DOI : 10.1038/sj.bjp.0702190
The role of endocannabinoids in the regulation of gastric emptying: alterations in mice fed a high-fat diet, British Journal of Pharmacology, vol.167, issue.Suppl 1, pp.1272-1280, 2008. ,
DOI : 10.1038/sj.bjp.0707682
Endocannabinoids and the gastrointestinal tract: what are the key questions?, British Journal of Pharmacology, vol.442, issue.3 Suppl, pp.663-670, 2007. ,
DOI : 10.1038/sj.bjp.0707422
Relationship between oral glucose tolerance and gastric emptying in normal healthy subjects, Diabetologia, vol.35, issue.9, pp.857-862, 1993. ,
DOI : 10.1007/BF00400362
Relationships between gastric emptying, intragastric meal distribution and blood glucose concentrations in diabetes mellitus, J Nucl Med, vol.36, pp.2220-2228, 1995. ,
Small Bowel Motility Affects Glucose Absorption in a Healthy Man, Diabetes Care, vol.25, issue.10, pp.1857-1861, 2002. ,
DOI : 10.2337/diacare.25.10.1857
Postprandial glucose regulation: New data andnew implications, Clinical Therapeutics, vol.27, pp.42-56, 2005. ,
DOI : 10.1016/j.clinthera.2005.11.020
The Importance of Hyperglycemia in the Nonfasting State to the Development of Cardiovascular Disease, Endocrine Reviews, vol.19, issue.5, pp.583-592, 1998. ,
DOI : 10.1210/edrv.19.5.0343
Kinetic analysis of hexose transport to determine the mechanism of amygdalin and prunasin absorption in the intestine, Journal of Applied Toxicology, vol.55, issue.5, pp.371-375, 2003. ,
DOI : 10.1002/jat.934
The spontaneously diabetic Torii rat with gastroenteropathy, Diabetes Research and Clinical Practice, vol.75, issue.2, pp.127-134, 2007. ,
DOI : 10.1016/j.diabres.2006.06.034
Antagonism of peripheral hepatic cannabinoid receptor-1 improves liver lipid metabolism in mice: Evidence from cultured explants, Hepatology, vol.74, issue.Suppl 1, pp.790-799, 2012. ,
DOI : 10.1002/hep.24733
URL : https://hal.archives-ouvertes.fr/inserm-01344467
The serum D-xylose test as a useful tool to identify malabsorption in rats with antigen specific gut inflammatory reaction, International Journal of Experimental Pathology, vol.56, issue.1, pp.141-147, 2009. ,
DOI : 10.1111/j.1365-2613.2008.00627.x
Molecular physiology of sodium-glucose cotransporters, Physiol Rev, vol.74, pp.993-1026, 1994. ,
Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist, Biochemical Pharmacology, vol.46, issue.5, pp.791-796, 1993. ,
DOI : 10.1016/0006-2952(93)90486-G
Update on incretin hormones Fatty acid amide hydrolase controls mouse intestinal motility in vivo, Ann N Y Acad Sci Gastroenterology, vol.1243129, pp.55-74, 2005. ,
Endocannabinoids as physiological regulators of colonic propulsion in mice, Gastroenterology, vol.123, issue.1, pp.227-234, 2002. ,
DOI : 10.1053/gast.2002.34242
receptors in the gastrointestinal tract: a regulatory system in states of inflammation, British Journal of Pharmacology, vol.132, issue.(Suppl 2), pp.263-270, 2008. ,
DOI : 10.1038/sj.bjp.0707486
Emerging role of cannabinoids in gastrointestinal and liver diseases: basic and clinical aspects, Gut, vol.57, issue.8, pp.1140-1155, 2008. ,
DOI : 10.1136/gut.2008.148791
Intestinal sugar transport, World Journal of Gastroenterology, vol.12, issue.11, pp.1657-1670, 2006. ,
DOI : 10.3748/wjg.v12.i11.1657
Acute Enterocyte Adaptation to Luminal Glucose: A Posttranslational Mechanism for Rapid Apical Recruitment of the Transporter GLUT2, Journal of Gastrointestinal Surgery, vol.278, issue.2, pp.312-319, 2012. ,
DOI : 10.1007/s11605-011-1752-y
The facilitated component of intestinal glucose absorption, The Journal of Physiology, vol.89, issue.15P, pp.585-595, 2001. ,
DOI : 10.1111/j.1469-7793.2001.0585h.x
Mechanisms of glucose uptake in intestinal cell lines: Role of GLUT2, Surgery, vol.151, issue.1, pp.13-25, 2012. ,
DOI : 10.1016/j.surg.2011.07.010
Lack of a significant effect of cannabinoids upon the uptake of 2-deoxy-D-glucose by Caco-2 cells, Pharmacology, vol.82, pp.30-37, 2008. ,
Biology of Incretins: GLP-1 and GIP, Gastroenterology, vol.132, issue.6, pp.2131-2157, 2007. ,
DOI : 10.1053/j.gastro.2007.03.054
Treatment of Type 2 diabetes mellitus with agonists of the GLP-1 receptor or DPP-IV inhibitors, Expert Opinion on Emerging Drugs, vol.52, issue.1, pp.155-166, 2004. ,
DOI : 10.2337/diabetes.52.2.380
Effect of exenatide on gastric emptying and relationship to postprandial glycemia in type 2 diabetes, Regulatory Peptides, vol.151, issue.1-3, pp.123-129, 2008. ,
DOI : 10.1016/j.regpep.2008.07.003
The effect of gastric inhibitory polypeptide on intestinal glucose absorption and intestinal motility in mice, Biochemical and Biophysical Research Communications, vol.404, issue.1, pp.115-120, 2011. ,
DOI : 10.1016/j.bbrc.2010.11.077
HU-308: A specific agonist for CB2, a peripheral cannabinoid receptor, Proceedings of the National Academy of Sciences, vol.96, issue.25, pp.14228-14233, 1999. ,
DOI : 10.1073/pnas.96.25.14228
Cannabinoid CB2 receptors in the enteric nervous system modulate gastrointestinal contractility in lipopolysaccharidetreated rats Effects of cannabinoid receptor-2 activation on accelerated gastrointestinal transit in lipopolysaccharide-treated rats, Am J Physiol Gastrointest Liver Physiol Br J Pharmacol, vol.295142, pp.78-87, 2004. ,
Involvement of CB1 and CB2 receptors in the modulation of cholinergic neurotransmission in mouse gastric preparations, Pharmacological Research, vol.56, issue.3, pp.185-192, 2007. ,
DOI : 10.1016/j.phrs.2007.06.002
Effect of cannabinoids on neural transmission in rat gastric fundus, Canadian Journal of Physiology and Pharmacology, vol.80, issue.1, pp.67-76, 2002. ,
DOI : 10.1139/y02-005
AM630 behaves as a protean ligand at the human cannabinoid CB2 receptor, British Journal of Pharmacology, vol.149, issue.1, pp.2561-2574, 2012. ,
DOI : 10.1111/j.1476-5381.2011.01503.x
Analysis of the ???endocannabinoidome??? in peripheral tissues of obese Zucker rats, Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA), vol.89, issue.2-3, pp.127-135, 2013. ,
DOI : 10.1016/j.plefa.2013.06.002
Gastrointestinal Regulation of Food Intake: General Aspects and Focus on Anandamide and Oleoylethanolamide, Journal of Neuroendocrinology, vol.292, issue.s1, pp.39-46, 2008. ,
DOI : 10.1074/jbc.M604751200
The role of the endocannabinoid system in the control of energy homeostasis, International Journal of Obesity, vol.263, pp.33-38, 2006. ,
DOI : 10.1074/jbc.C500175200